Cargando…

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis

BACKGROUND: The mortality of Candida Bloodstream Infection (CBSI) remains high. Antifungal susceptibility breakpoints were recently updated for Candida species, the impact remains unknown. In this study we evaluated the impact of inappropriate antifungal treatment according to recent breakpoints on...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Lara, María Fernanda, Torres-González, Pedro, Cornejo-Juárez, Patricia, Velázquez-Acosta, Consuelo, Martinez-Gamboa, Areli, Rangel-Cordero, Andrea, Bobadilla-del-Valle, Miriam, Ostrosky-Zeichner, Luis, Ponce-de-León, Alfredo, Sifuentes-Osornio, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719515/ https://www.ncbi.nlm.nih.gov/pubmed/29212442 http://dx.doi.org/10.1186/s12879-017-2846-2

Ejemplares similares

2118. Antifungal Susceptibility Testing of Clinical Isolates of Aspergillus in Mexico
por: Gonzalez-Lara, María F, et al.
Publicado: (2019)

Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals
por: Corzo-Leon, Dora E., et al.
Publicado: (2014)

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage
por: Won, Eun Jeong, et al.
Publicado: (2015)

Breakpoints for the Classification of Anti-Candida Compounds in Antifungal Screening
por: Alves, Danielle da Nóbrega, et al.
Publicado: (2021)

First case of Nocardia amamiensis pulmonary infection in Mexico
por: Martinez-Gamboa, A., et al.
Publicado: (2016)

317. Invasive Fungal Infections in Critically-ill Patients with COVID-19 in Mexico City
por: Bojorges-Aguilar, Eduardo S, et al.
Publicado: (2021)

Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
por: Román-Montes, Carla M., et al.
Publicado: (2022)

Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2016)

847. Cryptococcal disease in HIV and non-HIV-infected patients: clinical features and outcome
por: Roman-Montes, Carla M, et al.
Publicado: (2023)

Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2012)

113. Accuracy of the NHSN Central Line-Associated Bloodstream Infection (CLABSI) Definition
por: Hammadi, Ahmed Al, et al.
Publicado: (2018)

Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
por: Al-Obaidi, Mohanad M, et al.
Publicado: (2023)

Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2015)

Prevalence of Latent and Active Tuberculosis among Dairy Farm Workers Exposed to Cattle Infected by Mycobacterium bovis
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2013)

Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
por: Ponce-de-Leon, Alfredo, et al.
Publicado: (2018)

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
por: Costa-de-Oliveira, Sofia, et al.
Publicado: (2020)

Importance of differentiating Mycobaterium bovis in tuberculous meningitis
por: González-Duarte, Alejandra, et al.
Publicado: (2011)

Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance
por: Bobadilla-del Valle, Miriam, et al.
Publicado: (2015)

Vancomycin-resistant Enterococci, Mexico City
por: Cuellar-Rodríguez, Jennifer, et al.
Publicado: (2007)

Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico
por: Roman-Montes, Carla M., et al.
Publicado: (2023)

Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis
por: Meletiadis, Joseph, et al.
Publicado: (2022)

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?
por: Ostrosky-Zeichner, Luis
Publicado: (2011)

Potential Effect of Statins on Mycobacterium tuberculosis Infection
por: Guerra-De-Blas, Paola Del Carmen, et al.
Publicado: (2018)

Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital
por: Marins, Tatiana Aporta, et al.
Publicado: (2018)

Isolation of Rhizopus microsporus and Lichtheimia corymbifera from tracheal aspirates of two immunocompetent critically ill patients with COVID-19
por: Fernández-García, Oscar, et al.
Publicado: (2021)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
por: Shealy, Stephanie C., et al.
Publicado: (2020)

782. Risk Factors, Clinical Characteristic, and Treatment Outcomes for Nontuberculous Mycobacterial Disease in Mexico
por: Luis, Bruno Ali Lopez, et al.
Publicado: (2018)

Outbreak of NDM-1-Producing Escherichia coli in a Coronavirus Disease 2019 Intensive Care Unit in a Mexican Tertiary Care Center
por: Fernández-García, Oscar A., et al.
Publicado: (2022)

Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong
por: Seneviratne, Chaminda J., et al.
Publicado: (2016)

Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey
por: Dagi, Hatice Turk, et al.
Publicado: (2016)

146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018
por: Tesini, Brenda L, et al.
Publicado: (2020)

In Vitro Antifungal Activity of Manogepix and Other Antifungal Agents against South African Candida auris Isolates from Bloodstream Infections
por: Maphanga, Tsidiso G., et al.
Publicado: (2022)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

2375. Association Between Clostridium difficile Colonization and Inflammatory Bowel Disease Activity
por: Morado-Aramburo, Oscar, et al.
Publicado: (2019)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020)

Investigational Agents for the Treatment of Resistant Yeasts and Molds
por: Seiler, Garret T., et al.
Publicado: (2021)

Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections
por: Rezazadeh, Elham, et al.
Publicado: (2016)

Invasive Candida parapsilosis Bloodstream Infections in Children: The Antifungal Susceptibility, Clinical Characteristics and Impacts on Outcomes
por: Wang, Yao-Sheng, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
por: Bian, Xingchen, et al.
Publicado: (2022)

Nontuberculous mycobacterial infection in a tertiary care center in Mexico, 2001–2017
por: Lopez-Luis, Bruno Ali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nhcblkk5ilaaqfalc5h497l34v